Main menu
Click categories to expand
A-Z listingplugin-autotooltip__plain plugin-autotooltip_bigA-Z listing
This is an alphabetical index of all content pages.
Other categories
Utilities
Also see
Importance Ratings
News
Legal
Donate/Sponsor
Curator's rationale
AI Policy
Twitter feed ð•
Feeds + s.e.o. etc.
rss / xml feed 
sitemap file
A-Z listing (archived)
Triptans, sold under the brandnames Imitrex, Zomig, Amerge, Maxalt, Relpax and others, are a range of highly effective drugs used to treat Migraineplugin-autotooltip__plain plugin-autotooltip_bigMigraine
"Chronic migraine has a great detrimental influence on a patient’s life, with a severe impact on socioeconomic functioning and quality of life. Chronic migraine affects 1–2% of the general population, and about 8% of patients with migraine; it usually develop… and Cluster headacheplugin-autotooltip__plain plugin-autotooltip_bigCluster headache
"Cluster headache (CH) always involves pain that is one sided (although it can switch sides) and the main defining feature is the association with one or more of the 'cranial autonomic' features normally described as follows: • Reddening and tearing o….
The mechanism of action of the drugs has been debated since the 1980s.
It's currently thought that Triptans work by a (possible) combination of vaso-constriction and the blocking of 5-HT1D receptors, and/or because of its effects on nitric oxide levels.
[…] there was always a debate about its mechanism of action, and it still remains unclear today.“
Source : Wikipedia
Ideas for new topics, and suggested additions / corrections for older ones, are always welcome.
If you have skills or interests in a particular field, and have suggestions for Wikenigma, get in touch !
Or, if you'd like to become a regular contributor . . . request a login password. Registered users can edit the entire content of the site, and also create new pages.
( The 'Notes for contributors' section in the main menu has further information and guidelines etc.)
You are currently viewing an auto-translated version of Wikenigma
Please be aware that no automatic translation engines are 100% accurate, and so the auto-translated content will very probably feature errors and omissions.
Nevertheless, Wikenigma hopes that the translated content will help to attract a wider global audience.
DOKUWIKI IMPLEMENTATION DESIGN BY UNIV.ORG.UK DECEMBER 2023